Uniphar plc Stock price

Equities

UPR

IE00BJ5FQX74

Pharmaceuticals

Market Closed - Irish S.E. 12:55:00 2024-03-28 pm EDT 5-day change 1st Jan Change
2.6 EUR +0.78% Intraday chart for Uniphar plc -0.76% -3.70%
Sales 2023 2.55B 2.75B Sales 2024 * 2.66B 2.87B Capitalization 710M 766M
Net income 2023 44M 47.45M Net income 2024 * 51M 55M EV / Sales 2023 0.29 x
Net Debt 2023 * 198M 214M Net Debt 2024 * 208M 224M EV / Sales 2024 * 0.34 x
P/E ratio 2023
16.5 x
P/E ratio 2024 *
13.3 x
Employees 2,800
Yield 2023 *
0.7%
Yield 2024 *
0.74%
Free-Float 89.93%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.78%
1 week-0.76%
Current month-4.41%
1 month-3.35%
3 months-3.70%
6 months+13.54%
Current year-3.70%
More quotes
1 week
2.55
Extreme 2.545
2.72
1 month
2.55
Extreme 2.545
2.84
Current year
2.44
Extreme 2.44
3.00
1 year
1.98
Extreme 1.98
3.44
3 years
1.98
Extreme 1.98
5.08
5 years
0.97
Extreme 0.965
5.08
10 years
0.97
Extreme 0.965
5.08
More quotes
Managers TitleAgeSince
Chief Executive Officer - 10-02-28
Director of Finance/CFO 60 10-06-30
Investor Relations Contact - -
Members of the board TitleAgeSince
Chairman - 03-06-30
Director of Finance/CFO 60 10-06-30
Director/Board Member 64 19-06-26
More insiders
Date Price Change Volume
24-03-28 2.6 +0.78% 46,026
24-03-27 2.58 -3.73% 77,018
24-03-26 2.68 +1.13% 114,465
24-03-25 2.65 -1.12% 30,291
24-03-22 2.68 +2.29% 111,612

Real-time Irish S.E., March 28, 2024 at 12:55 pm EDT

More quotes
Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,800, the Group is active in Ireland, the United Kingdom, the Benelux, the Nordics, Germany and the United States. The Company's vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar plc represents a strong combination of scale, growth and profitability.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
2.6 EUR
Average target price
4.329 EUR
Spread / Average Target
+66.48%
Consensus
  1. Stock
  2. Equities
  3. Stock Uniphar plc - Irish S.E.